• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

51.47 -0.93 (-1.77%)
Official Closing Price Updated: 4:10 PM EST, Dec 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,851,726
Open 51.56
Bid (Size) 51.35 (900)
Ask (Size) 51.40 (1,600)
Prev. Close 52.40
Today's Range 51.34 - 51.99
52wk Range 43.08 - 93.80
Shares Outstanding N/A
Dividend Yield 4.27%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The 2026 Horizon: Wall Street Bets on the 'Application Era' and the Nuclear Renaissance
Today 14:35 EST
As the final trading days of 2025 come to a close, Wall Street is pivoting its focus from the hardware-driven "AI Gold Rush" toward a 2026 outlook defined by practical utility, autonomous software, and... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
Today 14:06 EST
The biopharmaceutical sector witnessed a dramatic surge in volatility today, December 29, 2025, as the industry careened toward the end of its strongest year in two decades. In a day defined by extreme... 
Via MarketMinute
Topics ETFs Intellectual Property

Performance

YTD
-41.2%
-41.2%
1 Month
+4.3%
+4.3%
3 Month
-7.3%
-7.3%
6 Month
-25.4%
-25.4%
1 Year
-40.0%
-40.0%

More News

Read More
News headline image
The Trillion-Dollar Apothecary: Inside Eli Lilly’s Era of Metabolic Dominance
Today 10:19 EST
Via PredictStreet
Topics Earnings Economy Intellectual Property
News headline image
Market Breather: Benchmarks Pause Record-Breaking Year as Volatility Signals Year-End Reset
Today 10:13 EST
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
This Beaten-Down Stock Just Jumped By 8%. Time to Buy? ↗
Today 9:05 EST
Via The Motley Fool
News headline image
Novo Nordisk Slashes Weight Loss Drug Price By Up To 50% In China: Report ↗
Today 7:14 EST
Via Stocktwits
Topics Intellectual Property
News headline image
The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA. ↗
Today 4:43 EST
Via The Motley Fool
News headline image
3 Drug Stocks to Buy at a Discount ↗
December 27, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Should You Invest in Ozempic Maker Novo Nordisk in 2026? ↗
December 26, 2025
Via The Motley Fool
News headline image
Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026 ↗
December 26, 2025
Via MarketBeat
News headline image
This Smallcap Pharma Stock Is Gaining Retail Buzz Ahead Of A Key FDA Ruling ↗
December 26, 2025
Via Stocktwits
News headline image
Buying This Pharmaceutical Stock Could Make You a Millionaire Retiree ↗
December 26, 2025
Via The Motley Fool
News headline image
Betting on the 'Santa Squeeze': Unusual Options Activity Surges as 2025 Draws to a Close
December 25, 2025
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle? ↗
December 25, 2025
Via The Motley Fool
News headline image
Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
December 25, 2025
Via MarketMinute
Topics Economy Intellectual Property
News headline image
The Oral Revolution: Novo Nordisk’s High-Stakes Bet on the Wegovy Pill
December 25, 2025
Via PredictStreet
Topics Economy Intellectual Property World Trade
News headline image
The Trillion-Dollar Pharma: A Deep Dive into Eli Lilly’s (LLY) Dominance in the Weight-Loss Era
December 25, 2025
Via PredictStreet
Topics Economy Government Intellectual Property
News headline image
The Weight of Innovation: Eli Lilly’s Dominance in the GLP-1 Era
December 24, 2025
Via PredictStreet
Topics Economy
News headline image
Novo Nordisk (NVO) Research: The Oral Wegovy Pivot and the 2026 Outlook
December 24, 2025
Via PredictStreet
Topics Economy Intellectual Property
News headline image
Hims & Hers Hit A GLP-1 Speed Bump This Year — But Growth Is Just Cooling, Not Cracking ↗
December 24, 2025
Via Stocktwits
News headline image
Novo Nordisk A/S-Spons ADR (NYSE:NVO): A Prime Candidate for Steady Dividend Income ↗
December 24, 2025
Via Chartmill
News headline image
Stock Market Today, Dec. 23: U.S. Stocks Hold Near Records on Narrow Tech-Led Gains ↗
December 23, 2025
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
Why Novo Nordisk Stock Popped Today ↗
December 23, 2025
Via The Motley Fool
News headline image
Novo Nordisk Stock Soars as "Wegovy Pill" Gains FDA Approval, Reshaping Obesity Market
December 23, 2025
Via MarketMinute
News headline image
Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill ↗
December 23, 2025
Via The Motley Fool
Topics Stocks

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 51.47
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 12/29/25 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap